BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neves M, Marinho-Dias J, Ribeiro J, Sousa H. Epstein-Barr virus strains and variations: Geographic or disease-specific variants? J Med Virol 2017;89:373-87. [PMID: 27430663 DOI: 10.1002/jmv.24633] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Corvalán AH, Ruedlinger J, de Mayo T, Polakovicova I, Gonzalez-Hormazabal P, Aguayo F. The Phylogeographic Diversity of EBV and Admixed Ancestry in the Americas⁻Another Model of Disrupted Human-Pathogen Co-Evolution. Cancers (Basel) 2019;11:E217. [PMID: 30769835 DOI: 10.3390/cancers11020217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol 2021. [PMID: 34705104 DOI: 10.1007/s00432-021-03824-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wu S, Liu W, Li H, Zhao Z, Yang Y, Xiao H, Song Y, Luo B. Conservation and polymorphism of EBV RPMS1 gene in EBV-associated tumors and healthy individuals from endemic and non-endemic nasopharyngeal carcinoma areas in China. Virus Res 2018;250:75-80. [PMID: 29665370 DOI: 10.1016/j.virusres.2018.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Cyprian FS, Al-Antary N, Al Moustafa AE. HER-2/Epstein-Barr virus crosstalk in human gastric carcinogenesis: A novel concept of oncogene/oncovirus interaction. Cell Adh Migr 2018;12:1-4. [PMID: 28562165 DOI: 10.1080/19336918.2017.1330244] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
6 Varvatsi D, Richter J, Tryfonos C, Pantzaris M, Christodoulou C. Association of Epstein-Barr virus latently expressed genes with multiple sclerosis. Mult Scler Relat Disord 2021;52:103008. [PMID: 34010765 DOI: 10.1016/j.msard.2021.103008] [Reference Citation Analysis]
7 Wanvimonsuk S, Thitiwanichpiwong P, Keelawat S, Mutirangura A, Kitkumthorn N. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population. J Med Virol 2019;91:444-9. [PMID: 30229949 DOI: 10.1002/jmv.25318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Padariya M, Kalathiya U, Mikac S, Dziubek K, Tovar Fernandez MC, Sroka E, Fahraeus R, Sznarkowska A. Viruses, cancer and non-self recognition. Open Biol 2021;11:200348. [PMID: 33784856 DOI: 10.1098/rsob.200348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kanda T, Yajima M, Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019;110:1132-1139. [PMID: 30697862 DOI: 10.1111/cas.13954] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
10 Wang H, Fu BB, Gale RP, Liang Y. NK-/T-cell lymphomas. Leukemia 2021;35:2460-8. [PMID: 34117356 DOI: 10.1038/s41375-021-01313-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abusalah MAH, Binti Hassan SA, Mat Lazim N, Abdullah B, Binti Wan Sohaimi WF, Husin A, Cheng KY, Yean CY. Design of InnoPrimers-Duplex Real-Time PCR for Detection and Treatment Response Prediction of EBV-Associated Nasopharyngeal Carcinoma Circulating Genetic Biomarker. Diagnostics (Basel) 2021;11:1761. [PMID: 34679459 DOI: 10.3390/diagnostics11101761] [Reference Citation Analysis]
12 Choi SJ, Jung SW, Huh S, Cho H, Kang H. Phylogenetic comparison of Epstein-Barr virus genomes. J Microbiol 2018;56:525-33. [PMID: 29948828 DOI: 10.1007/s12275-018-8039-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zhang JB, Huang SY, Wang TM, Dong SQ, He YQ, Zheng XH, Li XZ, Wang F, Jianbing M, Jia WH. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma. EBioMedicine 2018;37:101-9. [PMID: 30420297 DOI: 10.1016/j.ebiom.2018.10.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int 2022. [PMID: 35650445 DOI: 10.1007/s00296-022-05146-9] [Reference Citation Analysis]
15 Yakushina SA, Kisteneva LB. [Epstein-Barr virus (Herpesviridae: Gammaherpesvirinae: Lymphocryptovirus: Human gammaherpesvirus 4): replication strategies]. Vopr Virusol 2020;65:191-202. [PMID: 33533222 DOI: 10.36233/0507-4088-2020-65-4-191-202] [Reference Citation Analysis]
16 Mawson AR, Majumdar S. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma. Int J Cancer 2017;141:1849-55. [PMID: 28707393 DOI: 10.1002/ijc.30885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
17 Trier NH, Holm BE, Heiden J, Slot O, Locht H, Lindegaard H, Svendsen A, Nielsen CT, Jacobsen S, Theander E, Houen G. Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis. Sci Rep 2018;8:3684. [PMID: 29487382 DOI: 10.1038/s41598-018-22058-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
18 Gupta I, Al Farsi H, Jabeen A, Skenderi F, Al-Thawadi H, AlAhmad YM, Al Moustafa AE, Vranic S. High-Risk Human Papillomaviruses and Epstein-Barr Virus in Colorectal Cancer and Their Association with Clinicopathological Status. Pathogens 2020;9:E452. [PMID: 32521661 DOI: 10.3390/pathogens9060452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
19 Chou CT, Chang KC, Hsiao JR, Su YC, Ou CY. Metachronous occurrence of Epstein-Barr virus-associated primary ovarian Burkitt lymphoma and second primary nasopharyngeal carcinoma. Pathol Int 2022. [PMID: 35128744 DOI: 10.1111/pin.13206] [Reference Citation Analysis]
20 Alonso-Padilla J, Lafuente EM, Reche PA. Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus. J Immunol Res 2017;2017:9363750. [PMID: 29119120 DOI: 10.1155/2017/9363750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
21 Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. Oncotarget 2017;8:7248-64. [PMID: 28077791 DOI: 10.18632/oncotarget.14540] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
22 Gantuz M, Lorenzetti MA, Chabay PA, Preciado MV. A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association. PLoS One 2017;12:e0174221. [PMID: 28328987 DOI: 10.1371/journal.pone.0174221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
23 Blazquez AC, Berenstein AJ, Torres C, Izquierdo A, Lezama C, Moscatelli G, De Matteo EN, Lorenzetti MA, Preciado MV. Comprehensive Evolutionary Analysis of Complete Epstein-Barr Virus Genomes from Argentina and Other Geographies. Viruses 2021;13:1172. [PMID: 34207433 DOI: 10.3390/v13061172] [Reference Citation Analysis]
24 Weiss ER, Lamers SL, Henderson JL, Melnikov A, Somasundaran M, Garber M, Selin L, Nusbaum C, Luzuriaga K. Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection. J Virol 2018;92:e01466-17. [PMID: 29093087 DOI: 10.1128/JVI.01466-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
25 Nelson CS, Herold BC, Permar SR. A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection. NPJ Vaccines 2018;3:38. [PMID: 30275984 DOI: 10.1038/s41541-018-0074-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
26 Olotu FA, Soliman MES. Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus. Biomed J 2021;44:317-37. [PMID: 34154948 DOI: 10.1016/j.bj.2020.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kimura H. EBV in T-/NK-Cell Tumorigenesis. Adv Exp Med Biol 2018;1045:459-75. [PMID: 29896680 DOI: 10.1007/978-981-10-7230-7_21] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
28 Lam WKJ, Ji L, Tse OYO, Cheng SH, Jiang P, Lee PHP, Lin SV, Hui EP, Ma BBY, Chan ATC, Chan KCA, Chiu RWK, Lo YMD. Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles. Clin Chem 2020;66:598-605. [PMID: 32191318 DOI: 10.1093/clinchem/hvaa027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Liu J, Ji X, Shen Z, Wang PhD Y, Luo PhD B. Sequence variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinomas and healthy donors from southern and northern China. J Med Virol 2018;90:1629-35. [PMID: 29797589 DOI: 10.1002/jmv.25233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. EBV and the Pathogenesis of NK/T Cell Lymphoma. Cancers (Basel) 2021;13:1414. [PMID: 33808787 DOI: 10.3390/cancers13061414] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens 2021;10:763. [PMID: 34204243 DOI: 10.3390/pathogens10060763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]